Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study

Ítems similars

• Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
  per: Mizoguchi, Takanori, et al.
  Publicat: (2017)
• Effect of Topical Cyclosporine 0.05% in Allergic Conjunctivitis
  per: Sonali Bhalla, et al.
  Publicat: (2015-01-01)
• Comparison of the Safety and Efficacy of Loteprednol Etabonate 0.5%/Tobramycin 0.3% with Dexamethasone 0.1%/Tobramycin 0.3% Following Strabismus Surgery
  per: Salman, İlknur Akyol
  Publicat: (2016)
• Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
  per: Epstein, Arthur B, et al.
  Publicat: (2009)
• Double-masked, randomized, parallel-group study comparing olopatadine 0.1% ophthalmic solution with cromolyn sodium 2% and levocabastine 0.05% ophthalmic preparations in children with seasonal allergic conjunctivitis
  per: Ciprandi, Giorgio, et al.
  Publicat: (2004)